Corvus Pharmaceuticals (CRVS) Stock Chart & Stock Price History $5.79 +0.05 (+0.87%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$5.78 0.00 (-0.09%) As of 07:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Corvus Pharmaceuticals Stock Price Performance The Corvus Pharmaceuticals (CRVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.66%, with a year-to-date return of 8.22%. In the past month, the stock has increased 8.83%, reflecting recent market activity. As of the latest close, Corvus Pharmaceuticals traded at $5.79 with a market cap of $431.41 million and volume of 414,586 shares. Five years ago, the stock traded at $4.45, representing a 30.11% increase over that period. At the time, it had a market cap of $124.76 million and a volume of 264,183 shares. Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.69%1 Month Performance+8.83%3 Month Performance+47.33%Year-To-Date Performance+8.22%1 Year Performance+5.66%5 Year Performance+30.11% CRVS Stock Chart for Thursday, September, 18, 2025 CRVS Chart by TradingView Corvus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/17/2025$5.74$5.79+0.87%$6.04$5.72414,586 shs$431.41 million09/16/2025$5.88$5.74-2.38%$5.98$5.70383,550 shs$427.69 million09/15/2025$5.83$5.88+0.86%$5.92$5.64639,488 shs$438.14 million09/12/2025$6.06$5.83-3.80%$6.09$5.82412,662 shs$434.42 million09/11/2025$5.93$6.06+2.19%$6.08$5.90449,947 shs$451.53 million09/10/2025$6.17$5.93-3.89%$6.30$5.90576,422 shs$441.84 million09/09/2025$5.90$6.17+4.58%$6.25$5.90509,327 shs$459.75 million09/08/2025$6.16$5.90-4.22%$6.27$5.87790,563 shs$439.61 million09/05/2025$5.73$6.16+7.50%$6.17$5.741.12 million shs$458.98 million09/04/2025$5.62$5.73+1.96%$6.08$5.60677,590 shs$426.94 million Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/03/2025$5.67$5.62-0.88%$5.93$5.58565,507 shs$418.77 million09/02/2025$5.74$5.67-1.22%$5.99$5.60590,097 shs$422.47 million09/01/2025$5.74$5.74$5.75$5.34557,521 shs$427.69 million08/29/2025$5.41$5.74+6.10%$5.75$5.34557,521 shs$427.69 million08/28/2025$5.50$5.41-1.64%$5.56$5.28700,210 shs$403.12 million08/27/2025$5.54$5.50-0.72%$5.61$5.40700,376 shs$409.81 million08/26/2025$5.45$5.54+1.65%$5.62$5.46500,853 shs$412.79 million08/25/2025$5.55$5.45-1.80%$5.62$5.41337,577 shs$406.10 million08/22/2025$5.29$5.55+4.91%$5.64$5.22619,189 shs$413.55 million08/21/2025$5.19$5.29+1.93%$5.31$5.03365,140 shs$394.16 million08/20/2025$5.21$5.19-0.38%$5.22$5.06351,255 shs$386.71 million08/19/2025$5.32$5.21-2.07%$5.31$5.08447,231 shs$388.22 million08/18/2025$5.43$5.32-2.03%$5.81$5.24919,327 shs$396.39 million Related Companies Apogee Therapeutics Stock Price Chart Sarepta Therapeutics Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Cidara Therapeutics Stock Price Chart Vericel Stock Price Chart Phibro Animal Health Stock Price Chart Ardelyx Stock Price Chart Twist Bioscience Stock Price Chart Vera Therapeutics Stock Price Chart Edgewise Therapeutics Stock Price Chart Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRVS) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTen Bucks, Five Minutes... Could Send You Up to $8K QUARTERLYDOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
